Actively Recruiting
The Role of Ectopic Fat and Heart Attack Risk in HIV
Led by University of Liverpool · Updated on 2026-02-19
100
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed to investigate differences between people living with HIV (PLWHIV) and general populations on how the body utilises and stores energy. This study uses magnetic resonance imaging (MRI) to measure fat around the body organs including the heart and liver. The fat around body organs, also known as visceral fat, is known to be associated with metabolic syndrome and a risk factor for developing heart attacks and strokes. MRI scans are used frequently in hospitals to diagnose a range of conditions. These scans use radio waves to measure protons in body tissues. The machines can reconstruct tissues using complex algorithms to form composite images of body structures. MRI scans do not use ionising radiation and there is no risk to undertaking an MRI in terms of radiation. We often use MRI scans to assess the hearts' structure and function. In addition, we can use specific MRI sequences to assess the integrity of heart muscle. Heart MRI is often considered the gold standard imaging technique to assess the heart and heart muscle disease. This sub-study will use multiple MRI sequences to assess the heart and the liver. We are aiming to investigate any changes in heart and liver fat. In addition, we will assess any changes in fat levels within the heart muscle cells whilst also assessing for any change in the way the heart is functioning. PLWHIV have roughly double the risk of heart attacks compared to general populations. Previous studies have demonstrated that this increased risk may arise from the way in which fat is stored and metabolised in the body. We hope this study will give insight into why HIV-positive individuals have increased risks of heart attacks and how reducing visceral fat may reduce risk. It may lead to further medicines or treatment strategies to reduce the risk of heart attacks in HIV-positive individuals.
CONDITIONS
Official Title
The Role of Ectopic Fat and Heart Attack Risk in HIV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 40 years
- HIV-positive status
- Stable antiretroviral therapy for more than 6 months with viral load below 40 copies/ml
- CD4 count above 200 cells/mm3 for more than 2 years
- Ability to understand and comply with study procedures
- Voluntary written informed consent
You will not qualify if you...
- Unable to comply with study protocol
- History of severe kidney impairment (eGFR less than 30 ml/min)
- History of severe liver impairment (Child Pugh Score greater than 9)
- Active hepatitis B or hepatitis C infection
- Any active illness that prevents study participation
- History of cancer
- Active illicit intravenous drug use
- Any other abnormal screening results deemed relevant by investigators
- History or current use of GLP-1 agonists
- Pregnancy or breastfeeding for female participants
- Current use of atypical antipsychotics, omega 3 supplements, Telmisartan/Irbesartan, Thiazolidinediones, or regular NSAIDs
- Familial hypercholesterolaemia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal Liverpool University Hospital
Liverpool, United Kingdom
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here